Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-24 @ 10:22 PM
NCT ID:
NCT04002635
Eligibility Criteria:
Inclusion Criteria:
* Age more than or equal to 18 and less than or equal to 40
* BMI more than or equal to 18 and less than or equal to 35
* Diagnosis of PCOS according to Rotterdam criteria
* Normal gynaecological ultrasound \< 6 months before inclusion
* Signed informed consent form
* Day 5 or 6 frozen-thawed embryo transfer, blastocyst stage
Exclusion Criteria:
* Recurrent implantation failure
* Recurrent miscarriage
* Presence of adenomyosis
* Untreated intrauterine pathology
* rAFS (revised American Fertility Society) Grade III or IV endometriosis
* Hydrosalpinx
* In vitro maturation (IVM)
* Untreated autoimmune disorders
* (History of) malignancy
* Allergy or reaction to the use of progynova, utrogestan and/or letrozole in the past
* Pre-implantation genetic testing (PGT)
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT04002635
Study Brief:
Protocol Section:
NCT04002635